Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis

Rekha G Panchal1, Ricky L Ulrich, Steven B Bradfute

  • 1United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702-5011, USA. rekha.panchal@amedd.army.mil

Insights

Targeting the host phosphatase CD45 with inhibitors or reduced expression protected mice against Bacillus anthracis infection. Intermediate CD45 levels were crucial for this immune defense, highlighting a novel therapeutic strategy.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Cellular processes are modulated by small molecule inhibitors and gene manipulation to understand disease pathways.
  • Chemical genetic screening is a powerful tool for identifying key players in pathogenesis.

Purpose of the Study:

  • To identify host factors that modulate Bacillus anthracis infection using chemical genetic screening.
  • To investigate the role of host phosphatase CD45 in anthrax pathogenesis.

Main Methods:

  • Chemical genetic screening of phosphatase inhibitors against B. anthracis-infected macrophages.
  • Assaying compound sensitivity against a panel of phosphatases, focusing on CD45.
  • Utilizing CD45 inhibitors and antisense phosphorodiamidate morpholino oligomers (PMOs).
  • Conducting in vivo studies with gene-targeted knockdown and genetically engineered mice.
  • Mechanism-based studies to elucidate protective effects.

Main Results:

  • Several phosphatase inhibitors protected B. anthracis-infected macrophages; CD45 was the most sensitive target.
  • CD45 inhibition and reduced expression protected macrophages and mice from virulent B. anthracis infection.
  • Protection required intermediate CD45 levels; normal, absent, or inhibited phosphatase activity led to susceptibility.
  • Reduced CD45 expression did not protect against anthrax lethal toxin (LT), suggesting distinct signaling pathways.
  • Protection is linked to regulated immune cell homeostasis and reduced apoptosis during infection.

Conclusions:

  • Reduced host phosphatase CD45 levels modulate anthrax pathogenesis, offering a novel therapeutic target.
  • Host-directed therapies targeting CD45 may be effective against B. anthracis infections.
  • Distinct signaling pathways are involved in pathogen-induced cell death versus lethal toxin-induced effects.

Related Concept Videos

Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...